Salient Capital Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-82,587
Closed -$453K 61
2017
Q2
$453K Sell
82,587
-110,078
-57% -$628K 0.01% 159
2017
Q1
$1.11M Sell
192,665
-80,790
-30% -$443K 0.02% 125
2016
Q4
$1.34M Buy
273,455
+50,095
+22% +$270K 0.03% 110
2016
Q3
$1.36M Sell
223,360
-45,630
-17% -$273K 0.03% 105
2016
Q2
$1.59M Sell
268,990
-22,095
-8% -$119K 0.04% 105
2016
Q1
$1.51M Buy
291,085
+12,455
+4% +$57.3K 0.04% 102
2015
Q4
$1.24M Buy
278,630
+182,930
+191% +$894K 0.03% 111
2015
Q3
$469K Buy
95,700
+30,000
+46% +$163K 0.01% 166
2015
Q2
$401K Sell
65,700
-115,089
-64% -$711K 0.01% 197
2015
Q1
$1.04M Sell
180,789
-60,391
-25% -$375K 0.02% 137
2014
Q4
$1.5M Buy
241,180
+14,983
+7% +$94.6K 0.03% 125
2014
Q3
$1.48M Buy
226,197
+98,643
+77% +$695K 0.03% 132
2014
Q2
$898K Buy
127,554
+107,554
+538% +$791K 0.02% 147
2014
Q1
$148K Buy
+20,000
New +$140K ﹤0.01% 214

Other funds holding ABEV

Salient Capital Advisors's ABEV Position: Q3 2017 in Review

Salient Capital Advisors sold out of Ambev (ABEV) in Q3 2017, closing a stake of 82,587 shares — an estimated $453K sold.

Salient Capital Advisors first reported a position in ABEV in Q1 2014 and held it in 14 quarters. The position peaked at $1.59M in Q2 2016. 312 funds tracked by Wall St. Rank hold ABEV as of Q3 2017.

  • Salient Capital Advisors reported no remaining Ambev position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 82,587 Ambev shares in Q3 2017, an estimated $453K.
  • Salient Capital Advisors first reported a position in Ambev in Q1 2014 and held it in 14 quarters.
  • Salient Capital Advisors's Ambev position peaked at $1.59M in Q2 2016.
  • 312 funds tracked by Wall St. Rank held Ambev as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.